DAP.F
Danaher Corporation
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
187.60
▲ 0.35 (0.19%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
183.90
Prev close
187.25
Day high
187.60
Day low
183.90
Volume
272
Market cap
$131.88B
P/E (TTM)
39.08
52W range
137.80 – 208.30
Day trading desk
Gap from prior close
-1.79%
Prior close 187.25
VWAP
186.01
+0.86% from price
Relative volume
1.30×
Normal
Session range
2.01%
183.90 – 187.60
Position in range
100%
Near session high
ATR (14D)
4.14
2.21% of price
Prior day high
188.35
PDH
Prior day low
179.35
PDL
Bid / ask spread
—
Quote not published
Session volume
518
Avg 398
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+6.71%
+8.1%
1M
+11.93%
+8.2%
3M
+26.89%
+23.8%
6M
+6.51%
-4.6%
YTD
-3.88%
-16.2%
1Y
+6.35%
-13.6%
3Y
-12.36%
-86.5%
5Y
-24.95%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on DAP.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
77.05M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 4, 26 | RALES MITCHELL P Officer and Director |
STOCK | 500.00K | $0 | Direct |
| Aug 4, 26 | RALES STEVEN M Chairman of the Board |
STOCK | 500.00K | $0 | Direct |
| Aug 4, 26 | MILOSEVICH GREGORY M Officer |
STOCK | 15.40K | $0 | Direct |
| Aug 4, 26 | GUTIERREZ-RAMOS JOSE-CARLOS Officer |
STOCK | 13.48K | $0 | Direct |
| Aug 4, 26 | RILEY CHRISTOPHER PAUL Officer |
STOCK | 41.07K | $0 | Direct |
| Jul 15, 26 | FILLER LINDA Director |
CONVERSION | 3.30K | $237.06K | Direct |
| Jul 15, 26 | ZERHOUNI ELIAS A Director |
CONVERSION | 3.30K | $237.06K | Direct |
| May 15, 26 | SPOON ALAN G Director |
STOCK | 680 | $0 | Direct |
| May 15, 26 | LAMANNA CHARLES W Director |
STOCK | 680 | $0 | Direct |
| May 15, 26 | ZERHOUNI ELIAS A Director |
STOCK | 680 | $0 | Direct |
| May 15, 26 | STEVENS RAYMOND C Director |
STOCK | 680 | $0 | Direct |
| May 15, 26 | SANDERS A.SHANE Director |
STOCK | 680 | $0 | Direct |
| May 15, 26 | FILLER LINDA Director |
STOCK | 680 | $0 | Direct |
| May 15, 26 | DEWAN FEROZ Director |
STOCK | 680 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLAIR RAINER M |
Chief Executive Officer | 96.24K | Stock Award(Grant) |
FILLER LINDA |
Director | 48.42K | Conversion of Exercise of derivative security |
GUTIERREZ-RAMOS JOSE-CARLOS |
Officer | 32.49K | Stock Award(Grant) |
MCGREW MATTHEW |
Officer | 37.06K | Stock Award(Grant) |
RALES MITCHELL P |
Officer and Director | 27.51M | Stock Award(Grant) |
RALES STEVEN M |
Chairman of the Board | 34.63M | Stock Award(Grant) |
RILEY CHRISTOPHER PAUL |
Officer | 61.47K | Stock Award(Grant) |
SCHWIETERS JOHN T |
Director | 56.06K | Conversion of Exercise of derivative security |
SPOON ALAN G |
Director | 133.47K | Stock Award(Grant) |
ZERHOUNI ELIAS A |
Director | 52.80K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$131.88B
Enterprise value$155.40B
Revenue (TTM)$25.11B
Gross profit$14.75B
EBITDA$8.03B
Net income$3.99B
EPS (TTM)$4.80
Free cash flow$4.33B
Total cash$4.35B
Total debt$27.86B
Book value / share$64.01
Shares outstanding702.99M
Float625.83M
Short % of float—
Dividend yield0.74%
Beta (5Y)0.80
Valuation & profitability ratios
Trailing P/E39.08
Forward P/E19.16
PEG ratio1.43
Price / sales—
Price / book2.93
EV / revenue6.19
EV / EBITDA19.36
Gross margin58.75%
Operating margin19.78%
Profit margin15.95%
Return on equity7.61%
Return on assets3.95%
Debt / equity52.97
Current ratio1.65
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $24.57B | $23.88B | $23.89B | $26.64B | +2.9% |
| Operating revenue | $24.57B | $23.88B | $23.89B | $26.64B | +2.9% |
| Cost of revenue | $10.04B | $9.67B | $9.86B | $10.46B | +3.9% |
| Gross profit | $14.52B | $14.21B | $14.03B | $16.19B | +2.2% |
| Research & development | $1.60B | $1.58B | $1.50B | $1.53B | +0.9% |
| Selling, general & admin | $8.23B | $7.76B | $7.33B | $7.12B | +6.1% |
| Total operating expense | $9.83B | $9.34B | $8.83B | $8.65B | +5.2% |
| Operating income | $4.69B | $4.86B | $5.20B | $7.54B | -3.6% |
| Net interest income | -$235.00M | -$161.00M | $17.00M | -$163.00M | -46.0% |
| Pre-tax income | $4.23B | $4.65B | $5.04B | $7.15B | -8.9% |
| Tax provision | $633.00M | $747.00M | $823.00M | $818.00M | -15.3% |
| Net income | $3.61B | $3.90B | $4.76B | $7.21B | -7.3% |
| Net income to common | $3.61B | $3.90B | $4.74B | $7.10B | -7.3% |
| Basic EPS | 5.07 | 5.33 | 6.44 | 9.80 | -4.9% |
| Diluted EPS | 5.05 | 5.29 | 6.38 | 9.66 | -4.5% |
| EBIT | $4.50B | $4.92B | $5.33B | $7.35B | -8.7% |
| EBITDA | $6.95B | $7.28B | $7.50B | $9.48B | -4.5% |
| Basic shares | 712.70M | 731.00M | 736.50M | 725.10M | -2.5% |
| Diluted shares | 716.10M | 737.20M | 743.10M | 737.10M | -2.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.62B | $2.08B | $5.86B | $6.00B | +122.1% |
| Cash & short-term investments | $4.62B | $2.08B | $5.86B | $6.00B | +122.1% |
| Accounts receivable | $3.91B | $3.54B | $3.92B | $4.10B | +10.6% |
| Inventory | $2.49B | $2.33B | $2.59B | $2.77B | +6.8% |
| Total current assets | $12.76B | $9.50B | $13.94B | $15.88B | +34.3% |
| Property, plant & equipment | $5.53B | $4.99B | $4.55B | $3.71B | +10.8% |
| Goodwill & intangibles | $60.97B | $59.06B | $62.35B | $57.10B | +3.2% |
| Total assets | $83.46B | $77.54B | $84.49B | $84.35B | +7.6% |
| Total current liabilities | $6.81B | $6.80B | $8.27B | $8.39B | +0.1% |
| Current debt | $2.00M | $505.00M | $1.70B | $591.00M | -99.6% |
| Long-term debt | $18.42B | $15.50B | $16.71B | $19.09B | +18.8% |
| Total debt | $19.70B | $17.15B | $19.54B | $20.62B | +14.9% |
| Total liabilities | $30.92B | $27.99B | $31.00B | $34.26B | +10.5% |
| Retained earnings | $46.89B | $44.19B | $41.07B | $39.20B | +6.1% |
| Shareholder equity | $52.53B | $49.54B | $53.49B | $50.08B | +6.0% |
| Working capital | $5.95B | $2.70B | $5.66B | $7.49B | +120.4% |
| Net tangible assets | -$8.43B | -$9.52B | -$8.87B | -$7.01B | +11.4% |
| Shares issued | 886.90M | 884.30M | 880.50M | 869.30M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $3.60B | $3.90B | $4.22B | $6.33B | -7.7% |
| Depreciation & amortisation | $2.45B | $2.35B | $2.17B | $2.13B | +4.0% |
| Stock-based compensation | $298.00M | $288.00M | $306.00M | $295.00M | +3.5% |
| Change in working capital | -$719.00M | -$198.00M | -$470.00M | -$1.41B | -263.1% |
| Operating cash flow | $6.42B | $6.69B | $7.16B | $8.52B | -4.1% |
| Capital expenditure | -$1.16B | -$1.39B | -$1.38B | -$1.12B | +17.0% |
| Investing cash flow | -$1.20B | -$1.98B | -$7.08B | -$2.23B | +39.6% |
| Share buybacks | -$3.09B | -$5.98B | $0 | $0 | +48.4% |
| Dividends paid | -$878.00M | -$768.00M | -$1.25B | -$818.00M | -14.3% |
| Financing cash flow | -$2.96B | -$8.38B | -$273.00M | -$2.57B | +64.7% |
| Free cash flow | $5.26B | $5.30B | $5.78B | $7.40B | -0.7% |
| End cash position | $4.62B | $2.08B | $5.86B | $6.00B | +122.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | — | +5.3% |
| Operating revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | — | +5.3% |
| Cost of revenue | $2.65B | $2.36B | $2.87B | $2.53B | $2.41B | — | +12.5% |
| Gross profit | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | — | +0.6% |
| Research & development | $412.00M | $387.00M | $438.00M | $378.00M | $403.00M | — | +6.5% |
| Selling, general & admin | $2.07B | $1.86B | $2.03B | $1.99B | $2.36B | — | +11.4% |
| Total operating expense | $2.48B | $2.25B | $2.46B | $2.37B | $2.76B | — | +10.5% |
| Operating income | $1.13B | $1.34B | $1.50B | $1.15B | $760.00M | — | -16.1% |
| Net interest income | -$46.00M | -$36.00M | -$42.00M | -$64.00M | -$63.00M | — | -27.8% |
| Pre-tax income | $1.08B | $1.24B | $1.37B | $1.08B | $655.00M | — | -12.7% |
| Tax provision | $208.00M | $206.00M | $190.00M | $168.00M | $100.00M | — | +1.0% |
| Net income | $870.00M | $1.03B | $1.20B | $908.00M | $555.00M | — | -15.5% |
| Net income to common | $870.00M | $1.03B | $1.20B | $908.00M | $555.00M | — | -15.5% |
| Basic EPS | 1.23 | 1.45 | 1.69 | — | 0.77 | 1.33 | -15.2% |
| Diluted EPS | 1.23 | 1.45 | 1.68 | — | 0.77 | 1.32 | -15.2% |
| EBIT | $1.19B | $1.30B | $1.43B | $1.14B | $726.00M | — | -8.7% |
| EBITDA | $1.84B | $1.93B | $2.05B | $1.76B | $1.34B | — | -4.2% |
| Basic shares | 705.30M | 707.90M | 707.30M | — | 716.50M | 716.30M | -0.4% |
| Diluted shares | 707.60M | 711.20M | 711.00M | — | 719.10M | 720.80M | -0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.35B | $5.70B | $4.62B | $1.53B | $2.96B | -23.7% |
| Cash & short-term investments | $4.35B | $5.70B | $4.62B | $1.53B | $2.96B | -23.7% |
| Accounts receivable | $3.96B | $3.82B | $3.91B | $3.75B | $3.56B | +3.8% |
| Inventory | $3.26B | $2.61B | $2.49B | $2.67B | $2.69B | +25.0% |
| Total current assets | $13.38B | $13.94B | $12.76B | $9.61B | $11.00B | -4.0% |
| Property, plant & equipment | $5.83B | $5.47B | $5.53B | $5.38B | $5.31B | +6.5% |
| Goodwill & intangibles | $68.77B | $59.93B | $60.97B | $61.05B | $61.62B | +14.8% |
| Total assets | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | +10.6% |
| Total current liabilities | $8.11B | $7.46B | $6.81B | $6.32B | $6.79B | +8.6% |
| Current debt | $1.41B | $923.00M | $2.00M | $23.00M | $502.00M | +52.9% |
| Long-term debt | $25.15B | $17.56B | $18.42B | $16.83B | $16.85B | +43.2% |
| Total debt | $26.56B | $18.48B | $19.70B | $16.86B | $17.36B | +43.7% |
| Total liabilities | $39.77B | $30.59B | $30.92B | $28.82B | $29.28B | +30.0% |
| Retained earnings | $48.23B | $47.64B | $46.89B | $45.92B | $45.24B | +1.2% |
| Shareholder equity | $52.58B | $52.95B | $52.53B | $51.07B | $52.33B | -0.7% |
| Working capital | $5.28B | $6.47B | $5.95B | $3.28B | $4.21B | -18.5% |
| Net tangible assets | -$16.19B | -$6.98B | -$8.43B | -$9.97B | -$9.29B | -131.9% |
| Shares issued | 702.90M | 888.00M | 886.90M | 886.30M | 885.90M | -20.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $870.00M | $1.03B | $1.18B | $908.00M | $555.00M | -15.5% |
| Depreciation & amortisation | $659.00M | $627.00M | $623.00M | $622.00M | $611.00M | +5.1% |
| Stock-based compensation | $93.00M | $58.00M | $63.00M | $83.00M | $91.00M | +60.3% |
| Change in working capital | -$141.00M | -$469.00M | $146.00M | -$67.00M | -$395.00M | +69.9% |
| Operating cash flow | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | +16.0% |
| Capital expenditure | -$269.00M | -$237.00M | -$371.00M | -$292.00M | -$248.00M | -13.5% |
| Investing cash flow | -$10.15B | -$249.00M | -$384.00M | -$312.00M | -$258.00M | -3,975.1% |
| Share buybacks | -$894.00M | $0 | $0 | -$2.01B | $0 | — |
| Dividends paid | -$283.00M | -$226.00M | -$226.00M | -$229.00M | -$229.00M | -25.2% |
| Financing cash flow | $7.27B | $46.00M | $1.32B | -$2.78B | -$247.00M | +15,710.9% |
| Free cash flow | $1.26B | $1.08B | $1.75B | $1.37B | $1.09B | +16.6% |
| End cash position | $4.35B | $5.70B | $4.62B | $1.53B | $2.96B | -23.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $6.56B | +8.4% |
| Next quarter | — | — | $7.58B | +10.8% |
| Current year | — | — | $26.34B | +7.2% |
| Next year | — | — | $28.47B | +8.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders10.96%
Held by institutions84.51%
Institutions holding2.87K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
179.32
+4.62% from price
SMA 20
176.33
+6.39% from price
SMA 50
170.64
+9.94% from price
SMA 100
162.77
+15.26% from price
SMA 200
174.38
+7.58% from price
EMA 12
179.11
+4.74% from price
EMA 26
175.54
+6.87% from price
EMA 50
171.49
+9.39% from price
RSI (14)
65.1
Neutral
MACD (12,26,9)
3.57
Hist 0.93
ATR (14)
4.14
2.21% of price
Realised vol 30D
55.7%
Annualised
Bollinger upper
187.20
20, 2σ
Bollinger lower
165.45
20, 2σ
50 / 200 cross
Death
170.64 vs 174.38
Trend bias
Above 200
+7.58%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.00
Less volatile than market
Correlation to SPY
-0.00
Largely independent
Realised vol 30D
55.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-32.8%
Peak to trough
Max drawdown 5Y
-47.3%
Peak to trough
ATR 14
4.14
2.21% of price
Beta (reported)
0.80
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 22, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 22, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 22, 26 | Stifel | MAINTAINED | Buy | Buy |
| Jul 22, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 22, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jun 11, 26 | Piper Sandler | INITIATED | Neutral | Neutral |
| Jun 3, 26 | HSBC | MAINTAINED | Buy | Buy |
| May 27, 26 | Citigroup | DOWNGRADE | Buy | Neutral |
| Apr 23, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Apr 22, 26 | UBS | MAINTAINED | Buy | Buy |
| Apr 22, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate$1.39 / yr
Forward yield0.74%
5-year avg yield0.44%
Payout ratio25.67%
Ex-dividend dateJun 26, 2026
Next pay date—
Last split2:1
Split dateMay 21, 2004
Headlines
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Insider Monkey · 11m ago
Dow Jones Futures Fall With Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 13m ago
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
AFP · 17m ago
FIA Hails Success of Landmark INDYCAR Freedom 250 Grand Prix as Motorsport Takes Centre Stage in Washington D.C.
Business Wire · 21m ago
The next big oil trade may have nothing to do with oil stocks
TheStreet · 21m ago
First lady Melania Trump says she 'loved' racing as a child
USA TODAY · 21m ago
Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?
Insider Monkey · 22m ago
Crowder College offering training courses in August, September
The Joplin Globe, Mo. · 23m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.